Cancer metastasis: Biological and clinical aspects

Irish Journal of Medical Science

Volumn 167, Issue 1, 1998, Pages 4-8

  Duffy, M J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CELL ADHESION MOLECULE; INTEGRIN; MATRIX METALLOPROTEINASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEINASE; UROKINASE;

ANGIOGENESIS; CANCER INHIBITION; CARCINOGENESIS; CELL MOTILITY; CELL ONCOGENE; HUMAN; METASTASIS; MORBIDITY; MORTALITY; PROGNOSIS; PROTEIN EXPRESSION; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 0031952702     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02937542     Document Type: Short Survey

References (20)

1. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Twenty-eighth G. H. A. Clowes memorial Lecture. Cancer Res. 1990; 50: 6130-6138.
2. 125I-5-iododeoxyuridine. J. Natl. Cancer Inst. (U.S.). 1970; 45: 773-782.
3. Folkman, J., Shing, Y. Angiogenesis. J. Biol. Chem. 1992; 267: 10931-10934.
4. Felt, J. W., Strydom, D. L., Lob., R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., Valee, B. L. Isolation and characterisation of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24: 5480-5486.
5. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M. et al. Angiostastin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
6. O'Reilly, M. S., Holmgren, L., Chen, C., Folkman, J. Angiostatin induces and sustains dormancy of human pituitary tumors in mice. Nature Med. 1996; 2: 689-692.
7. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
8. Duffy, M. J. Role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis 1992; 10: 145-155.
9. Duffy, M. J. The biochemistry of metastasis. Adv. Clin. Chem. 1996; 32: 135-166.
10. Duffy, M. J. Urokinase plasminogen activator and malignancy. Fibrinolysis 1993; 7: 295-302.
11. Andreason, P. A., Kjoller, L., Christiansen, L., Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 1997; 72: 1-22.
12. Sloane, B. F., Moin, K., Krepela, E., Rozhin, J. Cathepsin B and its endogenous inhibitors: The role in tumor malignancy, Cancer Metastasis Rev. 1990; 9: 333-352.
13. Garcia, M., Platet, N., Liaudet, E., Laurent, V., Derocq, D., Brouillet, J-P., Rochefort, H. Biological and clinical significance of Cathepsin D in breast cancer metastasis. Stem Cells 1996; 14: 642-650.
14. MacDougall, J. R., Matrisian, L. M. Contribution of tumor and stromal matrix metalloproteinases to tumor progression invasion and metastasis. Cancer Met. Rev. 1995; 14: 351-362.
15. Menger, M. D., Vollmar, B. Adhesion molecules as determinants of disease from molecular biology to surgical research. Br. J. Surg. 1996; 83: 588-601.
16. Frenette, P. S., Wagner, D. D. Adhesion moleucles. N. Engl. J. Med. 1996; 334: 1526-1529.
17. Berg, E. L., McEvoy, L., Berlin, C., Bargatze, R., Butcher, E. C. L-selectin-mediated lymphocyte rolling on MadCAM-1. Nature (London) 1993; 366: 695-698.
18. Duffy, M. J., O'Grady, P, Devaney, D., O'Siorain, L., Fennelly, J. J., Lijnen, H. R. Urokinase-plasminogen activator, a marker for aggressive breast cancers, preliminary report. Cancer (Philadelphia) 1988; 62: 531-533.
19. Duffy, M. J., Reilly, D., O'Sullivan, C., O'Higgins, N., Fennelly, J. J., Andreasen, P. Urokinase plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res. 1990; 50: 6827-6829.
20. Duffy, M. J. Proteases as prognostic markers in cancer. Clin. Cancer Res. 1996; 2: 613-618.